Encompass Health Corp (EHC) stock
EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$142.11+1.12 (+0.79%)
Close on Nov 16, 2026Market cap $14.02BP/E 23.1Yield 0.51%
Encompass Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Encompass Health's operating cash flow for the twelve months ending Jun 30, 2026 was $1.21B, up 9.7% year over year. For fiscal 2025 it was $1.18B, up 17.2% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $1.18B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | +17.2% |
| FY2024 | Dec 31, 2024 | $1.00B | +17.9% |
| FY2023 | Dec 31, 2023 | $850.80M | +20.5% |
| FY2022 | Dec 31, 2022 | $705.80M | -1.4% |
| FY2021 | Dec 31, 2021 | $715.80M | +1.6% |
| FY2020 | Dec 31, 2020 | $704.70M | +10.9% |
| FY2019 | Dec 31, 2019 | $635.30M | -16.7% |
| FY2018 | Dec 31, 2018 | $762.40M | +15.8% |
| FY2017 | Dec 31, 2017 | $658.30M | +2.8% |
| FY2016 | Dec 31, 2016 | $640.20M | +27.5% |
| FY2015 | Dec 31, 2015 | $502.00M | +12.8% |
| FY2014 | Dec 31, 2014 | $444.90M | -5.4% |
| FY2013 | Dec 31, 2013 | $470.30M | +14.3% |
| FY2012 | Dec 31, 2012 | $411.50M | +20.1% |
| FY2011 | Dec 31, 2011 | $342.70M | +3.5% |
| FY2010 | Dec 31, 2010 | $331.00M | -18.5% |
| FY2009 | Dec 31, 2009 | $406.10M | +78.7% |
| FY2008 | Dec 31, 2008 | $227.20M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $282.60M | +4.6% |
| Q1 FY2026 | Mar 31, 2026 | $313.10M | +8.5% |
| Q4 FY2025 | Dec 31, 2025 | $346.00M | +24.1% |
| Q3 FY2025 | Sep 30, 2025 | $270.80M | +1.1% |
| Q2 FY2025 | Jun 30, 2025 | $270.20M | +24.3% |
| Q1 FY2025 | Mar 31, 2025 | $288.60M | +20.9% |
| Q4 FY2024 | Dec 31, 2024 | $278.80M | +38.7% |
| Q3 FY2024 | Sep 30, 2024 | $267.80M | +24.4% |
| Q2 FY2024 | Jun 30, 2024 | $217.40M | +5.2% |
| Q1 FY2024 | Mar 31, 2024 | $238.80M | +4.8% |
| Q4 FY2023 | Dec 31, 2023 | $201.00M | +16.7% |
| Q3 FY2023 | Sep 30, 2023 | $215.20M | +207.0% |
| Q2 FY2023 | Jun 30, 2023 | $206.70M | -15.5% |
| Q1 FY2023 | Mar 31, 2023 | $227.90M | +4.1% |
| Q4 FY2022 | Dec 31, 2022 | $172.20M | +39.1% |
| Q3 FY2022 | Sep 30, 2022 | $70.10M | -60.5% |
| Q2 FY2022 | Jun 30, 2022 | $244.60M | -4.4% |
| Q1 FY2022 | Mar 31, 2022 | $218.90M | +38.1% |
| Q4 FY2021 | Dec 31, 2021 | $123.80M | -55.7% |
| Q3 FY2021 | Sep 30, 2021 | $177.60M | +2.4% |
| Q2 FY2021 | Jun 30, 2021 | $255.90M | +15.1% |
| Q1 FY2021 | Mar 31, 2021 | $158.50M | +441.0% |
| Q4 FY2020 | Dec 31, 2020 | $279.70M | +29.7% |
| Q3 FY2020 | Sep 30, 2020 | $173.40M | +51.6% |
| Q2 FY2020 | Jun 30, 2020 | $222.30M | +52.9% |
| Q1 FY2020 | Mar 31, 2020 | $29.30M | -81.7% |
| Q4 FY2019 | Dec 31, 2019 | $215.60M | +20.9% |
| Q3 FY2019 | Sep 30, 2019 | $114.40M | -42.4% |
| Q2 FY2019 | Jun 30, 2019 | $145.40M | -14.1% |
| Q1 FY2019 | Mar 31, 2019 | $159.90M | -26.1% |
| Q4 FY2018 | Dec 31, 2018 | $178.40M | +17.8% |
| Q3 FY2018 | Sep 30, 2018 | $198.50M | +13.5% |
| Q2 FY2018 | Jun 30, 2018 | $169.20M | +11.9% |
| Q1 FY2018 | Mar 31, 2018 | $216.30M | +19.6% |
| Q4 FY2017 | Dec 31, 2017 | $151.40M | +7.5% |
| Q3 FY2017 | Sep 30, 2017 | $174.90M | -1.5% |
| Q2 FY2017 | Jun 30, 2017 | $151.20M | – |
| Q1 FY2017 | Mar 31, 2017 | $180.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $140.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $177.60M | – |
See a number that looks wrong?